查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1790458

临床检测设备和辅助解决方案市场规模、份额和趋势分析报告：按类型、阶段、地区和细分市场预测，2025 年至 2033 年

Clinical Trial Equipment & Ancillary Solutions Market Size, Share & Trends Analysis Report By Type (Sourcing, Supply/Logistics, Service), By Phase (Phase I, II, III, IV), By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

临床检测设备和辅助解决方案市场概览

预计全球临床检测设备和辅助解决方案市场在 2024 年的价值将达到 32.1 亿美元，到 2033 年将达到 68.8 亿美元，2025 年至 2033 年的复合年增长率为 8.92%。市场成长的动力来自于临床检测日益复杂和全球化，这需要高度专业化、特定于通讯协定的设备和物流支援。

分散式和混合式临床检测模式的迅速普及使得远端监控设备、穿戴式感测器和家用诊断试剂套件成为必需，从而大大扩展了辅助服务的范围。临床检测模式的转变，尤其是分散式检查和混合式检测的兴起，大大增加了对专用设备和支援服务的需求，以促进远端、无场地和居家研究环境。严重依赖集中式临床实验地点的传统模式正在被一种更加以患者为中心的方法所取代，这种模式需要远端监控设备、行动医疗套件、可穿戴设备以及用于生物样本的宅配物流。例如，美国FDA 正在透过其 2023 年指南草案推广分散式临床检测 (DCT)，敦促申办者采用数位健康技术和远端照护工具，以改善患者的可近性和数据品质。这些发展正在推动 CRO 和申办者采购可靠的温敏包装、检验的家用医疗设备以及即时追踪系统，以监督跨地区的设备运输。这种转变正在将临床测试设备供应商的角色从被动供应商转变为主动的综合服务合作伙伴，负责确保遵守法规、正确校准以及符合测试协议的交货时间表。

此外，政府和非营利资助机构越来越多地支持早期研究、转化医学和研究者主导的临床实验，所有这些都依赖于及时获得临床实验用品。美国国立卫生研究院的「我们所有人」研究计画和欧盟的「地平线欧洲」框架等倡议正在突破患者群体多样性和精准诊断的界限，需要製定适应性强且灵活的设备供应策略。例如，「地平线欧洲」已拨款约 1,114.9 亿美元（950 亿欧元）用于 2027 年之前的科学和创新，其中多个计划专注于个人化医疗、穿戴式监测和远端医疗综合临床测试。这些倡议正在创造对现场就绪套件、云端连接监测设备以及临床实验追踪的试剂和生技药品运输的需求。

目录

第一章调查方法与范围

第二章执行摘要

第三章临床检测设备和辅助解决方案市场：变数、趋势和范围

  • 市场体系展望
  • 临床检测设备和辅助解决方案市场动态
  • 科技
  • 定价模式分析
  • 临床测试设备和辅助解决方案市场：分析工具

第四章：临床检测设备和辅助解决方案市场：按类型估计和趋势分析

  • 细分仪表板
  • 全球临床检测设备和辅助解决方案市场类型变化分析
  • 全球临床检测设备及辅助解决方案市场规模及趋势分析（2021-2033）
  • 采购
    • 采购
    • 租赁
  • 供应/物流
    • 运输
    • 包装
    • 其他的
  • 服务
    • 校准
    • 设备维护
    • 其他的
  • 其他的

第五章：临床检测设备和辅助解决方案市场：阶段、估计和趋势分析

  • 细分仪表板
  • 全球临床检测设备和辅助解决方案市场的阶段波动分析
  • 全球临床检测设备和支援解决方案市场规模和趋势分析（分阶段，2021-2033）
  • 第一阶段
  • 第二阶段
  • 第三阶段
  • 第四阶段

第六章：临床检测设备和辅助解决方案市场：类型、阶段、区域、估计和趋势分析

  • 区域市场仪表板
  • 全球区域市场概况
  • 2021-2033 年市场规模、预测趋势分析
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争态势

  • 公司分类
    • 市场领导者
    • 新参与企业
  • 2024 年公司市场占有率/估值分析
  • 公司简介
    • Ancillare, LP
    • Imperial CRS, Inc.
    • Woodley Equipment Company Ltd.
    • Thermo Fisher Scientific, Inc.
    • Parexel International（MA）Corporation
    • Emsere
    • Quipment SAS
    • IRM
    • Marken
    • Myonex
    • Yourway
Product Code: GVR-4-68039-533-5

Clinical Trial Equipment & Ancillary Solutions Market Summary

The global clinical trial equipment & ancillary solutions market size was valued at USD 3.21 billion in 2024 and is projected to reach USD 6.88 billion by 2033, growing at a CAGR of 8.92% from 2025 to 2033. The growth of the market is due to the increasing complexity and globalization of clinical trials, which demand highly specialized, protocol-specific equipment and logistics support.

The rapid adoption of decentralized and hybrid trial models requires remote monitoring devices, wearable sensors, and home-use diagnostic kits, significantly expanding the scope of ancillary services. The transformation of clinical trial models, especially the increase of decentralized and hybrid trials, has significantly raised the demand for specialized equipment and support services that facilitate remote, site-less, and home-based research settings. The traditional model, which relied heavily on centralized trial sites, is being replaced by more patient-focused approaches, requiring remote monitoring devices, mobile health kits, wearables, and courier-enabled logistics for biological samples. For example, the U.S. FDA has promoted decentralized clinical trials (DCTs) through its 2023 draft guidance, urging sponsors to adopt digital health technologies and remote care tools to enhance patient access and data quality. These developments are leading CROs and sponsors to acquire reliable, temperature-sensitive packaging, validated medical devices for home use, and real-time tracking systems to oversee equipment shipments across different regions. This shift has transformed the role of clinical trial equipment suppliers from passive vendors into active, integrated service partners responsible for ensuring regulatory compliance, proper calibration, and delivery schedules aligned with study protocols.

Additionally, government and non-profit funding organizations are increasingly supporting early-stage research, translational medicine, and investigator-initiated trials, all of which depend on timely access to ancillary trial supplies. Initiatives like the NIH's All of Us Research Program and the European Union's Horizon Europe framework are expanding the boundaries of patient cohort diversity and precision diagnostics, which require adaptive and flexible equipment supply strategies. For example, Horizon Europe allocates nearly USD 111.49 billion (€95 billion) toward science and innovation through 2027, with multiple projects focused on personalized medicine, wearable monitoring, and telehealth-integrated clinical trials. These initiatives generate demand for site-ready kits, cloud-connected monitoring devices, and digitally traceable shipping for reagents and biologics.

Global Clinical Trials Equipment & Ancillary Solutions Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global clinical trial equipment & ancillary solutions market report based on type, phase and region.

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Sourcing
    • Procurement
    • Equipment
    • Ancillaries
    • Rental
    • Equipment
    • Ancillaries
  • Supply/Logistics
    • Transportation
    • Packaging
    • Others
  • Service
    • Calibrations
    • Equipment servicing
    • Others
  • Others
  • Phase Outlook (Revenue, USD Million, 2021 - 2033)
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Norway
    • Sweden
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Value chain based analysis (Model 2)
    • 1.7.3. Multivariate Analysis (Model 3)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Clinical Trial Equipment & Ancillary Solutions Market: Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. Clinical Trial Equipment & Ancillary Solutions Market Dynamics
    • 3.2.1. Market Driver Impact Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Technological Landscape
  • 3.4. Pricing Model Analysis
  • 3.5. Clinical Trial Equipment & Ancillary Solutions Market: Analysis Tools
    • 3.5.1. Porter's Five Forces Analysis
    • 3.5.2. PESTEL Analysis

Chapter 4. Clinical Trial Equipment & Ancillary Solutions Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Clinical Trial Equipment & Ancillary Solutions Market Type Movement Analysis
  • 4.3. Global Clinical Trial Equipment & Ancillary Solutions Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
  • 4.4. Sourcing
    • 4.4.1. Sourcing Market Estimates and Forecasts, 2021 - 2033 (USD million)
    • 4.4.2. Procurement
      • 4.4.2.1. Procurement Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.2.2. Equipment
        • 4.4.2.2.1. Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.2.3. Ancillaries
        • 4.4.2.3.1. Ancillaries Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. Rental
      • 4.4.3.1. Rental Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.2. Equipment
        • 4.4.3.2.1. Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.3. Ancillaries
        • 4.4.3.3.1. Ancillaries Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Supply/Logistics
    • 4.5.1. Supply/Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.2. Transportation
      • 4.5.2.1. Transportation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.3. Packaging
      • 4.5.3.1. Packaging Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.4. Others
      • 4.5.4.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Service
    • 4.6.1. Service Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.2. Calibrations
      • 4.6.2.1. Calibrations Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.3. Equipment servicing
      • 4.6.3.1. Equipment Servicing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.4. Others
      • 4.6.4.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Others
    • 4.7.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Clinical Trial Equipment & Ancillary Solutions Market: Phase Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Clinical Trial Equipment & Ancillary Solutions Market Phase Movement Analysis
  • 5.3. Global Clinical Trial Equipment & Ancillary Solutions Market Size & Trend Analysis, by Phase, 2021 to 2033 (USD Million)
  • 5.4. Phase I
    • 5.4.1. Phase I Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Phase II
    • 5.5.1. Phase II Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Phase III
    • 5.6.1. Phase III Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Phase IV
    • 5.7.1. Phase IV Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Clinical Trial Equipment & Ancillary Solutions Market: Regional Estimates & Trend Analysis by Type, Phase

  • 6.1. Regional Market Dashboard
  • 6.2. Global Regional Market Snapshot
  • 6.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 6.4. North America
    • 6.4.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Competitive Scenario
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Competitive Scenario
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Competitive Scenario
      • 6.4.4.3. Regulatory Framework
      • 6.4.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Europe
    • 6.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.4. France
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Competitive Scenario
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.5. Italy
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Competitive Scenario
      • 6.5.5.3. Regulatory Framework
      • 6.5.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.6. Spain
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Competitive Scenario
      • 6.5.6.3. Regulatory Framework
      • 6.5.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.7. Denmark
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Competitive Scenario
      • 6.5.7.3. Regulatory Framework
      • 6.5.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.8. Sweden
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Competitive Scenario
      • 6.5.8.3. Regulatory Framework
      • 6.5.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.9. Norway
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. Competitive Scenario
      • 6.5.9.3. Regulatory Framework
      • 6.5.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Competitive Scenario
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.5. Australia
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Competitive Scenario
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.6. South Korea
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Competitive Scenario
      • 6.6.6.3. Regulatory Framework
      • 6.6.6.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Competitive Scenario
      • 6.6.7.3. Regulatory Framework
      • 6.6.7.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Competitive Scenario
      • 6.7.2.3. Regulatory Framework
      • 6.7.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Competitive Scenario
      • 6.7.3.3. Regulatory Framework
      • 6.7.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. MEA
    • 6.8.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Competitive Scenario
      • 6.8.2.3. Regulatory Framework
      • 6.8.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Competitive Scenario
      • 6.8.3.3. Regulatory Framework
      • 6.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Competitive Scenario
      • 6.8.4.3. Regulatory Framework
      • 6.8.4.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Competitive Scenario
      • 6.8.5.3. Regulatory Framework
      • 6.8.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
    • 7.1.1. Market Leaders
    • 7.1.2. Emerging Players
  • 7.2. Company Market Share/Assessment Analysis, 2024
  • 7.3. Company Profiles
    • 7.3.1. Ancillare, LP
      • 7.3.1.1. Company overview
      • 7.3.1.2. Financial performance
      • 7.3.1.3. Service benchmarking
      • 7.3.1.4. Strategic initiatives
    • 7.3.2. Imperial CRS, Inc.
      • 7.3.2.1. Company overview
      • 7.3.2.2. Financial performance
      • 7.3.2.3. Service benchmarking
      • 7.3.2.4. Strategic initiatives
    • 7.3.3. Woodley Equipment Company Ltd.
      • 7.3.3.1. Company overview
      • 7.3.3.2. Financial performance
      • 7.3.3.3. Service benchmarking
      • 7.3.3.4. Strategic initiatives
    • 7.3.4. Thermo Fisher Scientific, Inc.
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Service benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Parexel International (MA) Corporation
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Service benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Emsere
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Service benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Quipment SAS
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Service benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. IRM
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Service benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Marken
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Service benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Myonex
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Service benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. Yourway
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Service benchmarking
      • 7.3.11.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America clinical trial equipment & ancillary solutions market, by region, 2021 - 2033 (USD Million)
  • Table 3 North America clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 4 North America clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 5 U.S. clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 6 U.S. clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 7 Canada clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 8 Canada clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 9 Europe clinical trial equipment & ancillary solutions market, by region, 2021 - 2033 (USD Million)
  • Table 10 Europe clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 11 Europe clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 12 Germany clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 13 Germany clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 14 UK clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 15 UK clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 16 France clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 17 France clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 18 Italy clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 19 Italy clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 20 Spain clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 21 Spain clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 22 Denmark clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 23 Denmark clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 24 Sweden clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 25 Sweden clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 26 Norway clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 27 Norway clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 28 Asia Pacific clinical trial equipment & ancillary solutions market, by region, 2021 - 2033 (USD Million)
  • Table 29 Asia Pacific clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 30 Asia Pacific clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 31 China clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 32 China clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 33 Japan clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 34 Japan clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 35 India clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 36 India clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 37 South Korea clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 38 South Korea clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 39 Australia clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 40 Australia clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 41 Thailand clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 42 Thailand clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 43 Latin America clinical trial equipment & ancillary solutions market, by region, 2021 - 2033 (USD Million)
  • Table 44 Latin America clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 45 Latin America clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 46 Brazil clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 47 Brazil clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 48 Mexico clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 49 Mexico clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 50 Argentina clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 51 Argentina clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 52 Colombia clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 53 Colombia clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 54 MEA clinical trial equipment & ancillary solutions market, by region, 2021 - 2033 (USD Million)
  • Table 55 MEA clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 56 MEA clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 57 South Africa clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 58 South Africa clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 59 Saudi Arabia clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 60 Saudi Arabia clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 61 UAE clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 62 UAE clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 63 Kuwait clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 64 Kuwait clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Clinical trial equipment & ancillary solutions market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Commodity flow analysis
  • Fig. 8 Value-Chain-Based Sizing & Forecasting
  • Fig. 9 QFD model sizing & forecasting
  • Fig. 10 Bottom-up approach
  • Fig. 11 Market snapshot
  • Fig. 12 Segment snapshot
  • Fig. 13 Segment snapshot
  • Fig. 14 Segment snapshot
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Parent market outlook, 2024 (USD Million)
  • Fig. 17 Ancillary market outlook, 2024 (USD Million)
  • Fig. 18 Clinical trial equipment & ancillary solutions market dynamics
  • Fig. 19 Porter's five forces analysis
  • Fig. 20 PESTEL analysis
  • Fig. 21 Clinical trial equipment & ancillary solutions market type outlook: Segment dashboard
  • Fig. 22 Clinical trial equipment & ancillary solutions market, by type segment: Market share, 2025 & 2033
  • Fig. 23 Sourcing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Procurement market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Equipment market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Ancillaries market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Rental market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Equipment market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Ancillaries market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Supply/Logistics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Transportation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Packaging market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Service market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Calibrations market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Equipment servicing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Clinical trial equipment & ancillary solutions market phase outlook: Segment dashboard
  • Fig. 39 Clinical trial equipment & ancillary solutions market, by phase segment: Market share, 2024 & 2033
  • Fig. 40 Phase I market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Phase II market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Phase III market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Phase IV market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Regional market: Key takeaways
  • Fig. 45 Regional marketplace: Key takeaways
  • Fig. 46 North America clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Key country dynamics
  • Fig. 48 US clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 Canada clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 Mexico clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Europe clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 UK clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 Germany clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 France clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 Italy clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 Spain clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 Denmark clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 Norway clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Sweden clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Asia Pacific clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 Japan clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 China clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 India clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 Australia clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 South Korea clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Thailand clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 83 Latin America clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 Brazil clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 Argentina clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 88 MEA clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 South Africa clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 91 Key country dynamics
  • Fig. 92 Saudi Arabia clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 93 Key country dynamics
  • Fig. 94 Kuwait clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 95 Key country dynamics
  • Fig. 96 UAE clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 97 Market participant categorization
  • Fig. 98 Heat map analysis